Thermo Fisher Scientific’s QualTrak is tailored for biologics development.
Thermo Fisher Scientific’s QualTrak is a comprehensive suite of quantitative polymerase chain reaction (qPCR) tools that includes various Applied Biosystems solutions. The product is tailored for biologics development, including monoclonal antibodies, cell and gene therapies, and vaccines.
Among the solutions in QualTrak are the QuantStudio 6 and 7 Pro-Real Time PCR Systems, as well as the TaqMan and TaqPath master mixes and assays. The TaqPath BactoPure master mix is designed to detect as low as one copy of DNA per microliter from bacterial, viral, fungal, and mammalian sources to ensure contamination-free drug product and accurate titers.
QualTrak comes with readily available compliance documentation to reduce the time needed to comply with internal quality systems and regulatory requirements. To support post-discovery steps, such as manufacturing quality control and biodistribution, all master mixes and assays are manufactured at an ISO 13485-certified, FDA registered facility that uses current good manufacturing practices.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.